GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clene Inc (FRA:84C) » Definitions » YoY Rev. per Sh. Growth

Clene (FRA:84C) YoY Rev. per Sh. Growth : 0.00% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clene YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Clene's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 was 0.00%.

Clene's Revenue per Share for the three months ended in Mar. 2024 was €0.00.

Clene YoY Rev. per Sh. Growth Historical Data

The historical data trend for Clene's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clene YoY Rev. per Sh. Growth Chart

Clene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
- - - -30.00 -14.29

Clene Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 200.00 -66.67 -66.67 -

Clene YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Clene's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(0.006-0.007)/ | 0.007 |
=-14.29 %

Clene's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2024 )
=(Revenue per Share (Q: Mar. 2024 )-Revenue per Share (Q: Mar. 2023 )) / | Revenue per Share (Q: Mar. 2023 )) |
=(0.001-0.001)/ | 0.001 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clene YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Clene's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Clene (FRA:84C) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clene Inc (FRA:84C) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
RANI LGVN KRON TPST TIL CTCX SYRS CLSD SLDB CRDF OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
CLNN:USA
Address
6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Website
https://www.clene.com
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

Clene (FRA:84C) Headlines

No Headlines